GT Biopharma Inc. (GTBP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GT Biopharma Inc.

    NASDAQ: GTBP · Real-Time Price · USD
    0.70
    0.06 (9.61%)
    At close: Oct 06, 2025, 3:59 PM
    0.71
    1.30%
    After-hours: Oct 06, 2025, 06:51 PM EDT

    GT Biopharma Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.44 -1.36 -40.54 -44.41
    PEG Ratio
    		 -0.02 -0.00 0.60 0.65
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 -3.46 1.38 72.16 117.58
    P/FCF Ratio
    		 -0.45 -1.16 -55.64 -165.08
    P/OCF Ratio
    		 -0.45 -1.16 -55.64 -165.08
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a 0.01 0.01 0.00
    Quick Ratio
    		 0.72 2.12 3.35 3.14
    Current Ratio
    		 0.72 2.12 3.35 3.14
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a -63.74 -2.66K -80.1
    Return on Equity
    		 7.88 -1.02 -1.78 -2.65
    Return on Assets
    		 -3.11 -0.54 -1.25 -1.8
    Return on Invested Capital
    		 8.60 -1.8 -1.79 -2.62
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist